203 related articles for article (PubMed ID: 31746434)
1. Long non‑coding RNA HCP5 promotes prostate cancer cell proliferation by acting as the sponge of miR‑4656 to modulate CEMIP expression.
Hu R; Lu Z
Oncol Rep; 2020 Jan; 43(1):328-336. PubMed ID: 31746434
[TBL] [Abstract][Full Text] [Related]
2. LncRNA HCP5 Regulates Pancreatic Cancer Progression by miR-140-5p/CDK8 Axis.
Yuan B; Guan Q; Yan T; Zhang X; Xu W; Li J
Cancer Biother Radiopharm; 2020 Nov; 35(9):711-719. PubMed ID: 32407143
[No Abstract] [Full Text] [Related]
3. lncRNA HCP5 acts as a ceRNA to regulate EZH2 by sponging miR‑138‑5p in cutaneous squamous cell carcinoma.
Zou S; Gao Y; Zhang S
Int J Oncol; 2021 Aug; 59(2):. PubMed ID: 34195851
[TBL] [Abstract][Full Text] [Related]
4. LncRNA HCP5 promotes triple negative breast cancer progression as a ceRNA to regulate BIRC3 by sponging miR-219a-5p.
Wang L; Luan T; Zhou S; Lin J; Yang Y; Liu W; Tong X; Jiang W
Cancer Med; 2019 Aug; 8(9):4389-4403. PubMed ID: 31215169
[TBL] [Abstract][Full Text] [Related]
5. Functional role of long non-coding RNA CASC19/miR-140-5p/CEMIP axis in colorectal cancer progression
Wang XD; Lu J; Lin YS; Gao C; Qi F
World J Gastroenterol; 2019 Apr; 25(14):1697-1714. PubMed ID: 31011255
[TBL] [Abstract][Full Text] [Related]
6. LncRNA LINC00958 promotes tumor progression through miR-4306/CEMIP axis in osteosarcoma.
Zhou Y; Mu T
Eur Rev Med Pharmacol Sci; 2021 Apr; 25(8):3182-3199. PubMed ID: 33928604
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of long non‑coding RNA HCP5 suppresses the malignant behavior of retinoblastoma by sponging miR‑3619‑5p to target HDAC9.
Zhu Y; Hao F
Int J Mol Med; 2021 May; 47(5):. PubMed ID: 33693951
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA HCP5 functions as a sponge of miR-29b-3p and promotes cell growth and metastasis in hepatocellular carcinoma through upregulating DNMT3A.
Zhou Y; Li K; Dai T; Wang H; Hua Z; Bian W; Wang H; Chen F; Ai X
Aging (Albany NY); 2021 Jun; 13(12):16267-16286. PubMed ID: 34148029
[TBL] [Abstract][Full Text] [Related]
9. HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis.
Jiang L; Wang R; Fang L; Ge X; Chen L; Zhou M; Zhou Y; Xiong W; Hu Y; Tang X; Li G; Li Z
Theranostics; 2019; 9(9):2460-2474. PubMed ID: 31131047
[No Abstract] [Full Text] [Related]
10. LncRNA HCP5 promotes follicular thyroid carcinoma progression via miRNAs sponge.
Liang L; Xu J; Wang M; Xu G; Zhang N; Wang G; Zhao Y
Cell Death Dis; 2018 Mar; 9(3):372. PubMed ID: 29515098
[TBL] [Abstract][Full Text] [Related]
11. Down-regulation of HCP5 inhibits cell proliferation, migration, and invasion through regulating EPHA7 by competitively binding miR-101 in osteosarcoma.
Tu Y; Cai Q; Zhu X; Xu M
Braz J Med Biol Res; 2021; 54(2):e9161. PubMed ID: 33439936
[TBL] [Abstract][Full Text] [Related]
12. Role of lncRNAHCP5/microRNA-525-5p/PRC1 crosstalk in the malignant behaviors of ovarian cancer cells.
Wang L; He M; Fu L; Jin Y
Exp Cell Res; 2020 Sep; 394(1):112129. PubMed ID: 32511950
[TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA-NEAT1, a sponge for miR-98-5p, promotes expression of oncogene HMGA2 in prostate cancer.
Guo Z; He C; Yang F; Qin L; Lu X; Wu J
Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31481527
[TBL] [Abstract][Full Text] [Related]
14. The previously uncharacterized lncRNA APP promotes prostate cancer progression by acting as a competing endogenous RNA.
Shi X; Zhang W; Nian X; Lu X; Li Y; Liu F; Wang F; He B; Zhao L; Zhu Y; Ren S; Sun Y
Int J Cancer; 2020 Jan; 146(2):475-486. PubMed ID: 31107971
[TBL] [Abstract][Full Text] [Related]
15. Silencing of Long Noncoding RNA HLA Complex P5 (
Cheng R; Ji L; Su H; Wang L; Jia D; Yao X; Ji H
Biomed Res Int; 2022; 2022():3092063. PubMed ID: 35769676
[TBL] [Abstract][Full Text] [Related]
16. LncRNA MEG3 inhibits the progression of prostate cancer by modulating miR-9-5p/QKI-5 axis.
Wu M; Huang Y; Chen T; Wang W; Yang S; Ye Z; Xi X
J Cell Mol Med; 2019 Jan; 23(1):29-38. PubMed ID: 30565858
[TBL] [Abstract][Full Text] [Related]
17. Reciprocal regulation of PCGEM1 and miR-145 promote proliferation of LNCaP prostate cancer cells.
He JH; Zhang JZ; Han ZP; Wang L; Lv YB; Li YG
J Exp Clin Cancer Res; 2014 Sep; 33(1):72. PubMed ID: 25200485
[TBL] [Abstract][Full Text] [Related]
18. LncRNA BLACAT1 Promotes Proliferation, Migration and Invasion of Prostate Cancer Cells via Regulating miR-29a-3p/DVL3 Axis.
Liao B; Chen S; Li Y; Yang Z; Yang Y; Deng X; Ke S
Technol Cancer Res Treat; 2021; 20():1533033820972342. PubMed ID: 33641528
[TBL] [Abstract][Full Text] [Related]
19. LncRNA HCP5 promotes the development of cervical cancer by regulating MACC1 via suppression of microRNA-15a.
Yu Y; Shen HM; Fang DM; Meng QJ; Xin YH
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(15):4812-4819. PubMed ID: 30070314
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNA DANCR, working as a competitive endogenous RNA, promotes ROCK1-mediated proliferation and metastasis via decoying of miR-335-5p and miR-1972 in osteosarcoma.
Wang Y; Zeng X; Wang N; Zhao W; Zhang X; Teng S; Zhang Y; Lu Z
Mol Cancer; 2018 May; 17(1):89. PubMed ID: 29753317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]